Clinical Trial: A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients

U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07690319) titled 'A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients' on July 02.

Brief Summary: The aim of this study is to evaluate the effectiveness of early treatment with secukinumab in patients with moderate-to-severe hidradenitis suppurativa (HS) and assess its impact on disease progression using data from multiple European data sources. All data will be sourced from existing non-interventional study primary data collection, registries, and hospital cohorts that captured information collected in routine clinical practice, prior to and independent of this study.

Study Start Date: Oct. 15, 2026

Study ...